References
- Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche J-D, Coopersmith CM, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016;315(8):801–810. doi:https://doi.org/10.1001/jama.2016.0287.
- Sepsis Trust. (2020). The UK Sepsis Trust [ Online]. [cited 2020 Jan 20]; Available from: https://sepsistrust.org/
- Dolin HH, Papadimos TJ, Chen X, Pan ZK. Characterization of pathogenic sepsis etiologies and patient profiles: A novel approach to triage and treatment. Microbiol Insights 2019;12:1178636118825081. doi:https://doi.org/10.1177/1178636118825081.
- Choi S-H, Hong S-B, Ko G-B, Lee Y, Park HJ, Park S-Y, Moon SM, Cho O-H, Park K-H, Chong YP, et al. Viral infection in patients with severe pneumonia requiring intensive care unit admission. Am J Respir Crit Care Med 2012;186(4):325–332. doi:https://doi.org/10.1164/rccm.201112-2240OC.
- Phua J, Ngerng WJ, See KC, Tay C, Kiong T, Lim H, Chew M, Yip H, Tan A, Khalizah H, et al. Characteristics and outcomes of culture-negative versus culture-positive severe sepsis. Crit Care 2013;17:R202. doi:https://doi.org/10.1186/cc12896.
- Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrar R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rockwerg B. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock. Intensive Care Med 2016;43:304–377.
- Shetty AL, Thompson K, Byth K, Macaskill P, Green M, Fullick M, Lander H, Iredell J. Serum lactate cut-offs as a risk stratification tool for in-hospital adverse outcomes in emergency department patients screened for suspected sepsis. BMJ Open 2018;8:e015492. doi:https://doi.org/10.1136/bmjopen-2016-015492.
- Hoeboer SH, van der Geest PJ, Nieboer D, Groeneveld ABJ. The diagnostic accuracy of procalcitonin for bacteraemia: a systematic review and meta-analysis. Clin Microbiol Infect 2015;21(5):474–481. doi:https://doi.org/10.1016/j.cmi.2014.12.026.
- de Jong E, van Oers JA, Beishuizen A, Vos P, Vermeijden WJ, Haas LE, Loef BG, Dormans T, van Melsen GC, Kluiters YC, et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in the critically ill patient: a randomised, controlled, open-label trial. Lancet Infect Dis 2016;16(7):819–827. doi:https://doi.org/10.1016/S1473-3099(16)00053-0.
- Reny JL, Vuagnat AC, Ract MO, Benoit M, Safar M, Fagon J. Diagnosis and follow-up of infections in intensive care patients: value of C-reactive protein compared with other clinical and biological variables. Crit Care Med 2002;30(3):529–535. doi:https://doi.org/10.1097/00003246-200203000-00006.
- Li HX, Liu ZM, Zhao SJ, Zhang D, Wang SJ, Wang YS. Measuring both procalcitonin and C-reactive protein for a diagnosis of sepsis in critically ill patients. J Int Med Res 2014;42(4):1050–1059. doi:https://doi.org/10.1177/0300060514528483.
- Russwurm S, Vickers J, Meier-Hellmann A, Lösche W. Platelet and leukocyte activation correlate with the severity of septic organ dysfunction. Shock 2002;17:263–268. doi:https://doi.org/10.1097/00024382-200204000-00004.
- Adamzik M, Görlinger K, Peters J, Hartmann M. Whole blood impedance aggregometry as a biomarker for the diagnosis and prognosis of severe sepsis. Crit Care 2012;16:R204. doi:https://doi.org/10.1186/cc11816.
- Segre E, Pigozzi L, Lison D, Pivetta E, Bosco O, Vizio B, Suppo U, Turvani F, Morello F, Battista S, Moiraghi C. May thrombopoietin be a useful marker of sepsis severity assessment in patients with SIRS entering the emergency department? Clin Chem Lab Med 2014;52:1479–1483.
- Sharma B, Sharma M, Majumder M, Steier W, Sangal A, Kalawar M. Thrombocytopenia in septic shock patients–a prospective observational study of incidence, risk factors and correlation with clinical outcome. Anaesth Intensive Care 2007;35:874–880. doi:https://doi.org/10.1177/0310057X0703500604.
- Claushuis TA, van Vught LA, Scicluna BP, Wiewel MA, Klein Klouwenberg PMC, Hoogendijk AJ, Ong DSY, Cremer OL, Horn J, Franitza M, et al. Thrombocytopenia is associated with a dysregulated host response in critically ill sepsis patients. Blood 2016;127(24):3062–3072. doi:https://doi.org/10.1182/blood-2015-11-680744.
- Tridente A, Clarke GM, Walden A, McKechnie S, Hutton P, Mills GH, Gordon AC, Holloway PAH, Chiche J-D, Bion J, et al. Patients with faecal peritonitis admitted to European intensive care units: an epidemiological survey of the GenOSept cohort. Intensive Care Med 2014;40(2):202–210. doi:https://doi.org/10.1007/s00134-013-3158-7.
- Semeraro N, Ammollo CT, Semeraro F, Colucci M. Sepsis-associated disseminated intravascular coagulation and thromboembolic disease. Mediterr J Hematol I 2010;2(3):e2010024. doi:https://doi.org/10.4084/mjhid.2010.024.
- Ali I, Graham C, Dempsey-Hibbert NC. Immature platelet fraction as a useful marker in the aetiological determination of thrombocytopenia. Exp Hematol 2019;78:56–61. doi:https://doi.org/10.1016/j.exphem.2019.09.001.
- Barsam SJ, Psaila B, Forestier M, Page LK, Sloane PA, Geyer JT, Villarica GO, Ruisi MM, Gernsheimer TB, Beer JH, et al. Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia. Blood 2011;117(21):5723–5732. doi:https://doi.org/10.1182/blood-2010-11-321398.
- De Blasi RA, Cardelli P, Costante A, Sandri M, Mercieri M, Arcioni R. Immature platelet fraction in predicting sepsis in critically ill patients. Intensive Care Med 2013;39(4):636–643. doi:https://doi.org/10.1007/s00134-012-2725-7.
- Di Mario A, Garzia M, Leone F, Arcangeli A, Pagano L, Zini G. Immature platelet fraction (IPF) in hospitalized patients with neutrophilia and suspected bacterial infection. J Infect 2009;59(3):201–206. doi:https://doi.org/10.1016/j.jinf.2009.07.007.
- Timmermans K, Kox M, Vaneker M, van der Berg M, John A, van Laarhoven A, van der Hoeven H, Scheffer GJ, Pickkers P. Plasma levels of danger-associated molecular patterns are associated with immune suppression in trauma patients. Intensive Care Med 2016;42(4):551–561. doi:https://doi.org/10.1007/s00134-015-4205-3.
- Lee YL, King MB, Gonzalez RP, Brevard SB, Frotan MA, Gillespie MN, Simmons JD. Blood transfusion products contain mitochondrial DNA damage-associated molecular patterns: a potential effector of transfusion-related acute lung injury. J Surg Res 2014;191:286–289. doi:https://doi.org/10.1016/j.jss.2014.06.003.
- Tridente A. Sepsis 3 and the burns patient: Do we need sepsis 3.1? Scars Burns Healing 2018;4:1–7. doi:https://doi.org/10.1177/2059513118790658.
- NICE. (2017). Sepsis: recognition, diagnosis and early management [ Online]. [cited 2020 Jan 4]; Available from: https://www.nice.org.uk/guidance/ng51/chapter/recommendations
- Ljungström L, Andersson R, Jacobsson G. Incidences of community onset severe sepsis, sepsis-3 sepsis, and bacteremia in Sweden – A prospective population-based study. PLoS ONE 2019;14(12):e0225700. doi:https://doi.org/10.1371/journal.pone.0225700.
- Povoa P, Coelho L, Almeida E, Fernandes A, Mealha R, Moreira P, Sabino H. C-reactive protein as a marker of infection in critically ill patients. Clin Microbiol Infect 2005;11:101–108. doi:https://doi.org/10.1111/j.1469-0691.2004.01044.x.
- Schmit X, Vincent JL. The time course of blood C-reactive protein concentrations in relation to the response to initial antimicrobial therapy in patients with sepsis. Infection 2008;36:213–219. doi:https://doi.org/10.1007/s15010-007-7077-9.
- Lobo SM, Lobo FR, Bota DP, Lopes-Ferreira F, Soliman HM, Mélot C, Vincent JL. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 2003;123(6):2043–2049. doi:https://doi.org/10.1378/chest.123.6.2043.
- Dan L, Longxiang S, Gencheng H, Peng Y, Lixin X. Prognostic value of Procalcitonin in adult patients with sepsis: a systematic review and meta-analysis. PLoS One 2015;10(6):e0129450. doi:https://doi.org/10.1371/journal.pone.0129450.
- Müller B, Becker KL, Schächinger H, Rickenbacher PR, Huber PR, Zimmerli W, Ritz R. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000;28:977–983. doi:https://doi.org/10.1097/00003246-200004000-00011.
- Müller B, Harbarth S, Stolz D, Bingisser R, Mueller C, Leuppi J, Nusbaumer C, Tamm M, Christ-Crain M. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infect Dis 2007;7:10. doi:https://doi.org/10.1186/1471-2334-7-10.
- Nargis W, Ibrahim M, Ahamed BU. Procalcitonin versus C-reactive protein: usefulness as biomarker of sepsis in ICU patient. Int J Crit Illn Inj Sci 2014;4(3):195–199. doi:https://doi.org/10.4103/2229-5151.141356.
- Casserly B, Phillips G, Schorr C, Dellinger RP, Townsend SR, Osborn TM, Reinhart K, Selvakumar N, Levy MM. Lactate measurements in sepsis-induced tissue hypoperfusion: results from the Surviving Sepsis Campaign database. Crit Care Med 2015;43(3):567–573. doi:https://doi.org/10.1097/CCM.0000000000000742.
- Liu Z, Meng Z, Li Y, Zhao J, Wu S, Gou S, Wu H. Prognostic accuracy of the serum lactate level, the SOFA score and the qSOFA score for mortality among adults with sepsis. Scand J Trauma Resusc Emerg Med 2019;27(1):51. doi:https://doi.org/10.1186/s13049-019-0609-3.
- Chan T, Gu F. Early diagnosis of sepsis using serum biomarkers. Exp Rev Mol Diagn 2011;11(5):487–496. doi:https://doi.org/10.1586/erm.11.26.
- Koyama K., Katayama S., Muronoi T., Tonai K., Goto Y., Koinuma T., Nunomiya S. Time course of immature platelet count and its relation to thrombocytopenia and mortality in patients with sepsis. PloS one 2018;13(1):e0192064.
- Tridente A, Clarke GM, Walden A., Gordon AC, Hutton P, Chiche JD, Hollway PA, Mills GH, Bion J, Stüber F, Garrard C. Association between trends in clinical variables and outcome in intensive care patients with fecal peritonitis: analysis of the GenOSept cohort. Crit Care 2015;5(19):210.
- Hubert R, Rodrigues M, Andreguetto B., Santos TM, Gilberti MD, De Castro V, Annichino-Bizzacchi JM, Dragosavac D, Carvalho-Filho MA, De Paul EV. Association of the immature platelet fraction with sepsis diagnosis and severity. Sci Rep 2015;5:8019.